Your browser doesn't support javascript.
loading
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings.
Agrawal, Rupesh; Testi, Ilaria; Mahajan, Sarakshi; Yuen, Yew Sen; Agarwal, Aniruddha; Rousselot, Andres; Raje, Dhananjay; Gunasekeran, Dinesh Visva; Kon, Onn Min; Barisani-Asenbauer, Talin; Kempen, John H; Gupta, Amod; Jabs, Douglas A; Smith, Justine R; Bodaghi, Bahram; Zierhut, Manfred; DeSmet, Marc; Cluskey, Peter Mc; Agarwal, Mamta; Agarwal, Manisha; Aggarwal, Kanika; Agrawal, Mukesh; Al-Dhibi, Hassan; Androudi, Sofia; Asyari, Fatma; Balasundaram, Manohar Babu; Murthy, Kalpana Babu; Baglivo, Edoardo; Banker, Alay; Bansal, Reema; Basu, Soumyava; Behera, Digamber; Biswas, Jyotirmay; Carreño, Ester; Caspers, Laure; Chee, Soon Phaik; Chhabra, Romi; Cimino, Luca; Del Rio, Luz Elena Concha; Cunningham, Emmett T; Curi, Andrè Luiz Land; Das, Dipankar; Denisova, Ekaterina; Denniston, Alastair K; Errera, Marie-Hélène; Fonollosa, Alejandro; George, Amala; Goldstein, Debra A; Crosier, Yan Guex; Gurbaxani, Avinash.
Afiliação
  • Agrawal R; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
  • Testi I; Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
  • Mahajan S; Singapore Eye Research Institute, Singapore, Singapore.
  • Yuen YS; Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
  • Agarwal A; Byers Eye Institute, Stanford Medical School, Palo Alto, CA, United States.
  • Rousselot A; Department of Ophthalmology, National University Hospital, Singapore, Singapore.
  • Raje D; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Gunasekeran DV; Department of Ophthalmology, Universidad del Salvador of Buenos Aires, Buenos Aires, Argentina.
  • Kon OM; MDS Bioanalytics, Nagpur, India.
  • Barisani-Asenbauer T; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
  • Kempen JH; Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
  • Gupta A; Byers Eye Institute, Stanford Medical School, Palo Alto, CA, United States.
  • Jabs DA; Chest and Allergy Clinic, St Mary's Hospital, Imperial College Heathcare Service Trust, London, United Kingdom.
  • Smith JR; OCUVAC - Centre of Ocular Inflammation and Infection, Laura Bassi Centre of Expertise, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Vienna, Austria.
  • Bodaghi B; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
  • Zierhut M; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • DeSmet M; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Cluskey PM; Flinders University College of Medicine and Public Health, Adelaide, Australia.
  • Agarwal M; Department of Ophthalmology, Sorbonne University, Paris, France.
  • Agarwal M; Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany.
  • Aggarwal K; Department of Ophthalmology ZNA Middelheim, Antwerp, Belgium.
  • Agrawal M; Department of Ophthalmology, Director Save Sight Institute, The University of Sydney, Sydney, Australia.
  • Al-Dhibi H; Sankara Nethralaya, Chennai, India.
  • Androudi S; Dr Shroff's Charity Eye Hospital Daryaganj, New Delhi, India.
  • Asyari F; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Balasundaram MB; VIMTA's Clinical Research and Clinical Reference Lab, Hyderabad, India.
  • Murthy KB; King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
  • Baglivo E; Department of Ophthalmology, University of Thessaly, Volos, Greece.
  • Banker A; INOIIS, Department of Ophthalmology, University of Indonesia, Indonesia.
  • Bansal R; Aravind Eye Care System, Coimbatore, India.
  • Basu S; Vittala International Institute of Ophthalmology, Bangalore, India.
  • Behera D; Department of Ophthalmology, Clinique de l'oeil, Geneva, Switzerland.
  • Biswas J; Banker's Retina Clinic and Laser Centre, 5 Subhash Society, Ahmedabad, India.
  • Carreño E; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Caspers L; LV Prasad Eye Institute, Bhubaneswar, India.
  • Chee SP; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Chhabra R; Sankara Nethralaya, Chennai, India.
  • Cimino L; Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain.
  • Del Rio LEC; Department of Ophthalmology, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Cunningham ET; Singapore Eye Research Institute, Singapore, Singapore.
  • Curi ALL; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Das D; Department of Ophthalmology, University of Manchester, Manchester, United Kingdom.
  • Denisova E; Ocular Immunology Unit, Azienda USL IRCCS, Reggio Emilia, Italy.
  • Denniston AK; Asociacion Para Evitar La Ceguera En Mexico, Mexico City, Mexico.
  • Errera MH; Department of Ophthalmology, California Pacific Medical Center, San Francisco, CA, USA.
  • Fonollosa A; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Brazil.
  • George A; Department of Ocular Pathology, Uveitis & Neuro-Ophthalmology Services, Sankaradeva Nethralaya, Guwahati, India.
  • Goldstein DA; Helmholtz Research Institute of Eye Diseases, Moscow, Russia.
  • Crosier YG; Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
  • Gurbaxani A; Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Ocul Immunol Inflamm ; 28(sup1): 85-95, 2020 Sep 30.
Article em En | MEDLINE | ID: mdl-32250731
ABSTRACT
An international, expert led consensus initiative was set up by the Collaborative Ocular Tuberculosis Study (COTS) group to develop systematic, evidence, and experience-based recommendations for the treatment of ocular TB using a modified Delphi technique process. In the first round of Delphi, the group identified clinical scenarios pertinent to ocular TB based on five clinical phenotypes (anterior uveitis, intermediate uveitis, choroiditis, retinal vasculitis, and panuveitis). Using an interactive online questionnaires, guided by background knowledge from published literature, 486 consensus statements for initiating ATT were generated and deliberated amongst 81 global uveitis experts. The median score of five was considered reaching consensus for initiating ATT. The median score of four was tabled for deliberation through Delphi round 2 in a face-to-face meeting. This report describes the methodology adopted and followed through the consensus process, which help elucidate the guidelines for initiating ATT in patients with choroidal TB.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Ocul Immunol Inflamm Assunto da revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Singapura

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Ocul Immunol Inflamm Assunto da revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Singapura